Evaluating molecular fingerprint-based models of drug side effects against a statistical control
- 1 November 2022
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 27 (11), 103364
- https://doi.org/10.1016/j.drudis.2022.103364
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Relating drug–protein interaction network with drug side effectsBioinformatics, 2012
- Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugsJournal of the American Medical Informatics Association, 2012
- Data-Driven Prediction of Drug Effects and InteractionsScience Translational Medicine, 2012
- Predicting drug side-effect profiles: a chemical fragment-based approachBMC Bioinformatics, 2011
- Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant TrialsDrug Safety, 2009
- SuperTarget and Matador: resources for exploring drug-target relationshipsNucleic Acids Research, 2007
- Overcoming the Winner’s Curse: Estimating Penetrance Parameters from Case-Control DataAmerican Journal of Human Genetics, 2007
- Medication-Attributed Adverse Effects in Placebo GroupsArchives of Internal Medicine, 2006
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999